全球胆囊癌市场按治疗类型、癌症类型、通路和地区划分

Gallbladder Cancer Market, By Treatment Type, By Cancer Type, By Distribution Channel, By Geography

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球胆囊癌市场规模估计为 8,080 万美元，预计到 2032 年将达到 1.1 亿美元，2025 年至 2032 年的复合年增长率为 4.5%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	8080万美元
效能数据	2020-2024	预测期	2025-2032
预测期：2025-2032年复合年增长率：	4.50%	2032年价值预测	1.1亿美元

胆囊癌是一种相对罕见的癌症，在老年女性中更为常见。胆囊癌通常在晚期发现，此时胆囊已无法手术切除。胆囊是一个小型梨形器官，位于腹部右侧，肝臟下方。胆囊储存胆汁，胆汁是由肝臟分泌的消化液。胆囊癌的危险因子包括胆结石、胆囊息肉、慢性胆囊炎和某些遗传性疾病。胆囊癌的症状包括腹痛（尤其是在右上腹部）、腹胀、发烧、体重不明原因下降、噁心以及皮肤和眼白髮黄（黄疸）。

市场动态：

预计未来几年全球胆囊癌治疗市场将显着成长。胆囊癌发生率的上升（主要集中在新兴市场）是市场成长的主要驱动力。诊断技术和治疗方法的进步也提高了患者的存活率和生活品质。例如，根据美国癌症协会发布的数据，2023年将新增约12,220例胆囊癌病例，其中男性5,750例，女性6,470例。

本研究的主要特点

本报告对全球胆囊癌市场进行了详细分析，并以 2024 年为基准年，提供了预测期 2025 年至 2032 年的市场规模和复合年增长率。
它还揭示了不同领域的潜在收益成长机会，并说明了该市场的引人注目的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
它根据公司亮点、产品系列、关键亮点、绩效和策略等参数，介绍了全球胆囊癌市场的主要企业概况。
研究涉及的主要企业包括礼来公司、百时美施贵宝、罗氏、辉瑞、诺华、默克公司、赛诺菲、Astra Zeneca、艾伯维和吉利德科学。
报告中的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球胆囊癌市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过分析全球胆囊癌市场所使用的各种策略矩阵来促进决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 80.8 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	4.50%	2032 Value Projection:	USD 110.0 Mn

Gallbladder cancer is a relatively rare cancer that is most common in older women. It is often discovered at its late stage, when it is no longer possible to remove the gallbladder surgically. The gallbladder is a small, pear-shaped organ on the right side of the abdomen, just beneath the liver. The gallbladder stores bile, a digestive fluid produced by liver. Risk factors for gallbladder cancer include gallstones, gallbladder polyps, chronic gallbladder inflammation, and certain inherited conditions. Symptoms of gallbladder cancer may include abdominal pain, particularly in the upper right portion of the abdomen, abdominal bloating, fever, unintended weight loss, nausea, and yellowing of the skin and the whites of the eyes (jaundice).

Market Dynamics:

The global market for gallbladder cancer treatment is expected to witness significant growth in the coming years. The rising incidence of gallbladder cancer, primarily in developing countries, is a major driver for market growth. Additionally, advancements in diagnostic techniques and treatment modalities are enhancing the survival rates and quality of life for patients. For instance, according to the data published by the American Cancer Society in, about 12,220 new cases of gallbladder cancer : 5,750 in men and 6,470 in women in 2023.

Key features of the study:

This report provides an in-depth analysis of the global gallbladder cancer market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global gallbladder cancer market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Eli Lilly and Company, Bristol-Myers Squibb, Roche, Pfizer, Novartis, Merck & Co., Inc., Sanofi, AstraZeneca, AbbVie, and Gilead Sciences
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global gallbladder cancer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gallbladder cancer market

Detailed Segmentation:

By Treatment Type
- Surgery
- Chemotherapy
- Radiation Therapy
- Immunotherapy
- Targeted Therapy
- Others
By Cancer Type
- Adenocarcinoma
- Squamous cell carcinoma
- Adenosquamous carcinoma
- Small cell carcinoma
- Undifferentiated carcinoma
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
By Region
- North America
- Europe
- APAC
- Latin America
- Middle East
- Africa
Company Profiles
- Eli Lilly and Company
- Bristol-Myers Squibb
- Roche
- Pfizer
- Novartis
- Merck & Co., Inc.
- Sanofi
- AstraZeneca
- AbbVie
- Gilead Sciences

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Gallbladder Cancer Market, By Treatment Type
- Gallbladder Cancer Market, By Cancer Type
- Gallbladder Cancer Market, By Distribution Channel
- Gallbladder Cancer Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing prevalence of gallbladder cancer
- High cost burden of cancer therapies
- Development of targeted therapies
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Gallbladder Cancer Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Gallbladder Cancer Market, By Treatment Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Chemotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Radiation Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Targeted Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

6. Gallbladder Cancer Market, By Cancer Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2020 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Adenocarcinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Squamous cell carcinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Adenosquamous carcinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Small cell carcinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

7. Gallbladder Cancer Market, By Distribution Channel, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2020 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

8. Gallbladder Cancer Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2020 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 - 2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - U.K.
  - Germany
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - China
  - Japan
  - India
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Region/Country, 2020-2032, (US$ Mn)
South Africa
North Africa
Central Africa

9. Competitive Landscape

Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristol-Myers Squibb
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Roche
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pfizer
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novartis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AbbVie
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Gilead Sciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

10. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

全球胆囊癌市场按治疗类型、癌症类型、通路和地区划分